Company news: Merck, Gilead
Merck preps the Street for Singulair's generic onslaught, and Gilead is poised to advance an all-oral Hep C. regimen into ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.